Biobot Analytics

Biobot Analytics operates a B2B software-and-data model. It collects and models wastewater-derived biological signals, packages the resulting intelligence into software platforms and licensed datasets, and sells access to public-sector and enterprise customers. Value is created through proprietary data collection and analytics, with customers using the outputs for surveillance, forecasting, operational planning, research, and clinical trial optimisation.

Biobot Analytics is a US health data and analytics company focused on wastewater intelligence. Its core offering is a proprietary platform and dataset that converts wastewater sampling into population-level insights on pathogens, substances, and genomic indicators, delivered through dashboards, exports, and APIs. The company serves public health agencies, government bodies, healthcare systems, and pharmaceutical or life sciences organisations that need early detection, forecasting, and geographically granular health monitoring.

The business generates revenue through contract-based SaaS access, data licensing, and enterprise or government agreements tied to surveillance coverage, sampling cadence, and access levels. Its value proposition is based on privacy-preserving, aggregated health intelligence derived from wastewater rather than individual patient data, which positions it as an infrastructure layer for public health surveillance, clinical trial planning, and health-related commercial analysis.